title: Differences in prostate and adipose tissue basic fibroblast growth factor: analysis of preliminary results.
abstract: OBJECTIVE
  Basic fibroblast growth factor (bFGF or FGF-2) is mitogenic to human prostate epithelial and stromal cells, and it is reported to be elevated in the serum and urine of patients with various cancers, including prostate cancer. Obesity, with increased body fat, is a risk factor for prostate cancer through unknown mechanisms. Because adipose tissue is a source of FGF-2, we determined the quantity and quality of activity of FGF-2 in omental adipose tissue and compared it with normal and cancerous prostate tissues.
  
  
  METHODS
  Using heparin-Sepharose chromatography, we extracted proteins from human omental adipose tissue, adenocarcinoma of the prostate, and benign prostatic hypertrophic (BPH) tissues. Each of the mitogenic proteins eluted with NaCl concentrations between 1.4 M and 1.8 M, similar to control FGF-2. Using FGF-2 antisera (which inhibited the mitogenic activity of the proteins), we performed Western blot analysis to confirm their homology to FGF-2. We also assessed recovery, mitogenicity, and angiogenicity of each of the proteins using thymidine incorporation into human umbilical vein endothelial cells and the chorioallantoic membrane assay.
  
  
  RESULTS
  There was greater recovery of FGF-2 from omental adipose tissue compared with cancerous or BPH homogenates (40 micrograms [2.0 micrograms/g] versus 25 micrograms [1.25 micrograms/g] and 20 micrograms [1.0 microgram/g], respectively). Moreover. FGF-2 from adipose tissue had greater mitogenic activity (96.2% versus 74.8% and 54%; P < 0.05) and a greater angiogenic activity (5.1 vessels versus 2.9 and 1.8 vessels; P < 0.05) on the chorioallantoic assay.
  
  
  CONCLUSIONS
  We suggest that human omental adipose tissue FGF-2 may demonstrate greater mitogenic and angiogenic activity than either BPH or prostate cancer tissue FGF-2. It is not known whether FGF-2 from adipose tissue qualitatively or quantitatively may underlie the relationship between obesity and prostate cancer.
authors.affiliation: Department of Urology, State University of New York Health Science Center at Brooklyn 11203, USA.
authors.forename: J H
authors.initials: JH
authors.lastname: Mydlo
authors.forename: J G
authors.initials: JG
authors.lastname: Kral
authors.forename: R J
authors.initials: RJ
authors.lastname: Macchia
mesh_terms: D000273:Adipose Tissue / Q000737:chemistry*; D000818:Animals; D015153:Blotting, Western; D002642:Chick Embryo; D016222:Fibroblast Growth Factor 2 / Q000032:analysis* / Q000502:physiology; D006801:Humans; D008297:Male; D018919:Neovascularization, Physiologic; D011467:Prostate / Q000737:chemistry*
chemical_list: D016222:Fibroblast Growth Factor 2